Page 210

American Medical Association. 1984. Report of Ad Hoc Commission on Vaccines Injury Compensation. Chicago.

American Medical Association, Ad Hoc Panel on Pertussis Vaccine Injury. 1985. Pertussis vaccine injury. Journal of the American Medical Association 254:30833085.

American Psychiatric Association. 1968. Diagnostic and statistical manual of mental disorders, 2nd edition (DSM II). Washington, DC: American Psychiatric Association.

American Psychiatric Association. 1980. Diagnostic and statistical manual of mental disorders, 3rd edition (DSM III). Washington, DC: American Psychiatric Association.

American Psychiatric Association. 1987. Diagnostic and Statistical Manual of Mental Disorders, 3rd edition, revised (DSM III-R). Washington, DC: American Psychiatric Association.

Amiel SA. 1976. The effects of Bordetella pertussis vaccine on cerebral vascular permeability. British Journal of Experimental Pathology 57:653-662.

Amiel-Tison C. 1973. Neurologic disorders in neonates associated with abnormalities of pregnancy and birth. Current Problems of Pediatrics 3:3-37.

Anderson EK. 1953. Serological studies on H. pertussis, H. parapertussis, and H. bronchisepticus. Acta Pathologica Microbiologica Scandinavica 33:202-224.

Anderson EL, Belshe RB, Bartram J. 1985. Clinical evaluation of acellular pertussis DT vaccine in young children. Abstract E27. Presented at the 85th Annual Meeting of the American Society for Microbiology, Las Vegas.

Anderson EL, Belshe RB, Bartram J, Gurwith M, Hung P, Levner M, Vernon SK. 1987. Clinical and serologic responses to acellular pertussis vaccine in infants and young children. American Journal of Diseases of Children 141:949-953.

Anderson EL, Belshe RB, Bartram J. 1988. Differences in reactogenicity and antigenicity of acellular and standard pertussis vaccines combined with diphtheria and tetanus in infants. Journal of Infectious Diseases 157:731-737.

Anderson GR. 1976. Problems associated with the development and clinical testing of an improved pertussis vaccine. In: Perlman D, ed. Advances in Applied Microbiology, Vol. 20. Madison, WI: Academic Press.

Anderson I, Morris D. 1950. Encephalopathy after combined diphtheria-pertussis inoculation. Lancet 1:537-539.

Anderson R, May R. 1982. The logic of vaccination. New Scientist 96:410-415.

Angell M. 1990. The interpretation of epidemiologic studies. New England Journal of Medicine 323:823-825.

Annegers JF, Hauser WA, Shirts SB, Kurland LT. 1987. Factors prognostic of unprovoked seizures after febrile convulsions. New England Journal of Medicine 316:493498.

Annegers JF, Hauser WA, Beghi E, Nicolosi A, Kurland LT. 1988. The risk of unprovoked seizures after encephalitis and meningitis. Neurology 38:1407-1410.

Aoyama T, Murase Y, Kato T, Iwata T. 1985. Efficacy of an acellular pertussis vaccine in Japan. Journal of Pediatrics 107:180-183.

Aoyama T, Hagiwara S, Murase Y, Kato T, Iwata T. 1986. Adverse reactions and antibody responses to acellular pertussis vaccine. Journal of Pediatrics 109:925930.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement